Alimera Sciences, Inc. ASZ1.F Stock
Alimera Sciences, Inc. Price Chart
Alimera Sciences, Inc. ASZ1.F Financial and Trading Overview
| Alimera Sciences, Inc. stock price | 2.88 EUR |
| Previous Close | 2.5 EUR |
| Open | 2.53 EUR |
| Bid | 2.67 EUR x N/A |
| Ask | 2.77 EUR x N/A |
| Day's Range | 2.53 - 2.53 EUR |
| 52 Week Range | 1.24 - 7.54 EUR |
| Volume | 500 EUR |
| Avg. Volume | 103 EUR |
| Market Cap | 25.3M EUR |
| Beta (5Y Monthly) | 1.381773 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.23 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 14.83 EUR |
ASZ1.F Valuation Measures
| Enterprise Value | 61.43M EUR |
| Trailing P/E | N/A |
| Forward P/E | -2.3211007 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.45363733 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 1.101 |
| Enterprise Value/EBITDA | -7.586 |
Trading Information
Alimera Sciences, Inc. Stock Price History
| Beta (5Y Monthly) | 1.381773 |
| 52-Week Change | -50.49% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 7.54 EUR |
| 52 Week Low | 1.24 EUR |
| 50-Day Moving Average | 1.93 EUR |
| 200-Day Moving Average | 3.25 EUR |
ASZ1.F Share Statistics
| Avg. Volume (3 month) | 103 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 8.81M |
| Float | 4.05M |
| Short Ratio | N/A |
| % Held by Insiders | 19.40% |
| % Held by Institutions | 28.59% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:15 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -30.69% |
| Operating Margin (ttm) | -19.35% |
| Gross Margin | 85.07% |
| EBITDA Margin | -14.51% |
Management Effectiveness
| Return on Assets (ttm) | -13.74% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 55.78M EUR |
| Revenue Per Share (ttm) | 7.96 EUR |
| Quarterly Revenue Growth (yoy) | 13.90% |
| Gross Profit (ttm) | N/A |
| EBITDA | -8097000 EUR |
| Net Income Avi to Common (ttm) | -17134000 EUR |
| Diluted EPS (ttm) | -2.27 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 13.09M EUR |
| Total Cash Per Share (mrq) | 1.77 EUR |
| Total Debt (mrq) | 47.53M EUR |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 2.517 |
| Book Value Per Share (mrq) | -3.605 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -5971000 EUR |
| Levered Free Cash Flow (ttm) | 59.13K EUR |
Profile of Alimera Sciences, Inc.
| Country | Germany |
| State | GA |
| City | Alpharetta |
| Address | 6310 Town Square |
| ZIP | 30005 |
| Phone | 678 990 5740 |
| Website | https://alimerasciences.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 150 |
Alimera Sciences, Inc., a pharmaceutical company, engages in the development and commercialization of ophthalmic pharmaceuticals. It operates through United States, internationally, and Operating Cost segments. It offers ILUVIEN, an intravitreal implant for the treatment of diabetic macular edema (DME), which is a disease of the retina that affects individuals with diabetes and lead to severe vision loss and blindness; and to prevent relapse in recurrent non-infectious uveitis affecting the posterior segment of the eye. The company sells its products to physician offices, pharmacies, clinics, and hospitals through direct sales and distributors. It has a collaboration agreement with EyePoint Pharmaceuticals US, Inc. for the development and sale of insert technology to deliver other corticosteroids to the back of the eye for the treatment and prevention of eye diseases in humans or to treat diabetic macular edema. Alimera Sciences, Inc. was incorporated in 2003 and is headquartered in Alpharetta, Georgia.
Q&A For Alimera Sciences, Inc. Stock
What is a current ASZ1.F stock price?
Alimera Sciences, Inc. ASZ1.F stock price today per share is 2.88 EUR.
How to purchase Alimera Sciences, Inc. stock?
You can buy ASZ1.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Alimera Sciences, Inc.?
The stock symbol or ticker of Alimera Sciences, Inc. is ASZ1.F.
Which industry does the Alimera Sciences, Inc. company belong to?
The Alimera Sciences, Inc. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Alimera Sciences, Inc. have in circulation?
The max supply of Alimera Sciences, Inc. shares is 54.21M.
What is Alimera Sciences, Inc. Price to Earnings Ratio (PE Ratio)?
Alimera Sciences, Inc. PE Ratio is now.
What was Alimera Sciences, Inc. earnings per share over the trailing 12 months (TTM)?
Alimera Sciences, Inc. EPS is -0.23 EUR over the trailing 12 months.
Which sector does the Alimera Sciences, Inc. company belong to?
The Alimera Sciences, Inc. sector is Healthcare.